Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06442046 · ClinicalTrials.gov registry record · NA
Strengthening the Connections to Opportunities for Prevention Engagement
A NA study of Interpersonal Violence and Structural Violence, sponsored by Kevin Borrup.
- Recruiting
- Registry status
- NA
- Development phase
- 225
- Enrollment target
- 1
- Study location
NCT06442046: Recruiting NA study of Interpersonal Violence and Structural Violence, sponsored by Kevin Borrup.
NCT06442046 is a NA study of Interpersonal Violence and Structural Violence that is actively recruiting participants, run by Kevin Borrup. The registered enrollment target is 225 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06442046, a NA study of Interpersonal Violence and Structural Violence, is actively recruiting participants, sponsored by Kevin Borrup.
- RECRUITING
- Registry status
- NA
- Development phase
- 225 participants
- Enrollment target
- 1
- Study location
Study Summary
The Strengthening the Connections to Opportunities for Prevention Engagement (SCOPE) project will create a pathway for children and families from the City of Hartford to connect with a Connecticut Children's Care Coordinator (CC) in an effort to reduce levels of violence exposure.
Primary Outcome
A reduction in exposure as measured using the Violence Prevention Emergency Tool (VPET) that provides a range from 0 to 21 with a 4 or more considered elevated.
Conditions Studied
Interventions
- OTHER Treatment as usual
- OTHER Active Case Management
Study Locations (1)
Connecticut
- Connecticut Children's - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2024-08-19 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT06442046 shows while recruiting
NCT06442046 is an interventional study that assigns participants to a tested intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 2 conditions, with Interpersonal Violence appearing as the primary indexed condition, and to 2 interventions - of which Treatment as usual is the first listed.
NCT06442046 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT06442046 about?
NCT06442046 is a clinical study titled "Strengthening the Connections to Opportunities for Prevention Engagement". The Strengthening the Connections to Opportunities for Prevention Engagement (SCOPE) project will create a pathway for children and families from the City of Hartford to connect with a Connecticut Children's Care Coordinator (CC) in an effort to reduce levels of violence exposure.
What is the current status of trial NCT06442046?
This trial is currently recruiting. It is a NA study. The enrollment target is 225 participants. The study started on 2024-08-19. Estimated completion is 2026-06-30.
What conditions does trial NCT06442046 study?
This clinical trial studies the following conditions: Interpersonal Violence, Structural Violence.
What interventions are being tested in trial NCT06442046?
The interventions under investigation include: Treatment as usual (OTHER), Active Case Management (OTHER).
Who is sponsoring clinical trial NCT06442046?
This trial is sponsored by Kevin Borrup, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06442046 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Interpersonal Violence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06442046's enrollment target sits among peer trials
225 472nd of 2000 higher than 1,524 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03955445 · 225 participants · Phase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
- NCT04054310 · 225 participants · NA
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- NCT04480554 · 225 participants · Phase 2
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
- NCT04888104 · 225 participants
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI